Literature DB >> 14502431

Regulation of the expression of the prostate-specific antigen by claudin-7.

J-Y Zheng1, D Yu, M Foroohar, E Ko, J Chan, N Kim, R Chiu, S Pang.   

Abstract

Claudins are a family of proteins involved in forming tight junctions between cells. Here we describe two forms of claudin-7 (CLDN-7), a full-length form of CLDN-7 with 211 amino-acid residues and a C-terminal truncated form with 158 amino-acid residues. These two forms of CLDN-7 are able to regulate the expression of a tissue-specific protein, the prostate-specific antigen (PSA), in the LNCaP prostate cancer cell line. We also found that the expression of CLDN-7 is responsive to androgen stimulation in the LNCaP cell line, suggesting that this protein is involved in the regulatory mechanism of androgen. Both forms of claudin-7 are expressed in human prostate, kidney and lung samples, and in most samples, the full-length form of claudin-7 was predominant. However, in some prostate samples from healthy individuals, the truncated form of claudin-7 is predominantly expressed. Our results demonstrated that unlike other claudins, CLDN-7 has both structural and regulatory functions, and the two forms of CLDN-7 may be related to cell differentiation in organ development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502431     DOI: 10.1007/s00232-003-2038-4

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  34 in total

Review 1.  Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels.

Authors:  F A Vicini; E M Horwitz; J Gonzalez; A A Martinez
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

2.  Screening for carcinoma of the prostate with prostate specific antigen.

Authors:  F Muschenheim; B Omarbasha; P M Kardjian; E N Mondou
Journal:  Ann Clin Lab Sci       Date:  1991 Nov-Dec       Impact factor: 1.256

Review 3.  Tight junctions and the molecular basis for regulation of paracellular permeability.

Authors:  J M Anderson; C M Van Itallie
Journal:  Am J Physiol       Date:  1995-10

4.  The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies.

Authors:  M G Oefelein; N Smith; M Carter; D Dalton; A Schaeffer
Journal:  J Urol       Date:  1995-12       Impact factor: 7.450

5.  COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos.

Authors:  Y Chen; C Merzdorf; D L Paul; D A Goodenough
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

6.  Manner of interaction of heterogeneous claudin species within and between tight junction strands.

Authors:  M Furuse; H Sasaki; S Tsukita
Journal:  J Cell Biol       Date:  1999-11-15       Impact factor: 10.539

7.  Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins.

Authors:  M Itoh; M Furuse; K Morita; K Kubota; M Saitou; S Tsukita
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

Review 8.  Pores in the wall: claudins constitute tight junction strands containing aqueous pores.

Authors:  S Tsukita; M Furuse
Journal:  J Cell Biol       Date:  2000-04-03       Impact factor: 10.539

9.  Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.

Authors:  N Sonoda; M Furuse; H Sasaki; S Yonemura; J Katahira; Y Horiguchi; S Tsukita
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

10.  A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts.

Authors:  M Furuse; H Sasaki; K Fujimoto; S Tsukita
Journal:  J Cell Biol       Date:  1998-10-19       Impact factor: 10.539

View more
  21 in total

1.  Expression patterns of claudin family of tight-junction proteins in the mouse prostate.

Authors:  Naoyuki Sakai; Hideki Chiba; Hiroki Fujita; Yushi Akashi; Makoto Osanai; Takashi Kojima; Norimasa Sawada
Journal:  Histochem Cell Biol       Date:  2007-01-27       Impact factor: 4.304

2.  Two common human CLDN5 alleles encode different open reading frames but produce one protein isoform.

Authors:  Ronald M Cornely; Barbara Schlingmann; Whitney S Shepherd; Joshua D Chandler; David C Neujahr; Michael Koval
Journal:  Ann N Y Acad Sci       Date:  2017-04-26       Impact factor: 5.691

Review 3.  Claudins and the modulation of tight junction permeability.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

4.  Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.

Authors:  Arun K Nalla; Theodore F Williams; Casey P Collins; Dustin T Rae; Grant D Trobridge
Journal:  Mol Carcinog       Date:  2015-10-29       Impact factor: 4.784

Review 5.  Emerging multifunctional roles of Claudin tight junction proteins in bone.

Authors:  Fatima Z Alshbool; Subburaman Mohan
Journal:  Endocrinology       Date:  2014-04-23       Impact factor: 4.736

6.  Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.

Authors:  Adam H Johnson; Henry F Frierson; Alexander Zaika; Steven M Powell; James Roche; Sheila Crowe; Christopher A Moskaluk; Wa'el El-Rifai
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

7.  Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST.

Authors:  Kassondra Meyer; Brittany Albaugh; Barry Schoenike; Avtar Roopra
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

8.  Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer.

Authors:  Kyung Won Seo; Young Kee Kwon; Byung Hoon Kim; Chun Il Kim; Hyuk Soo Chang; Mi Sun Choe; Choal Hee Park
Journal:  Korean J Urol       Date:  2010-04-20

9.  Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas.

Authors:  Erika Rendón-Huerta; Fortoul Teresa; Gorráez María Teresa; Garcia-Samper Xochitl; Alvarez-Fernández Georgina; Zavala-Zendejas Veronica; Luis Felipe Montaño
Journal:  J Gastrointest Cancer       Date:  2009-12-04

Review 10.  Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.

Authors:  Yosuke Hashimoto; Kiyohito Yagi; Masuo Kondoh
Journal:  Pflugers Arch       Date:  2016-09-15       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.